Drawing for INCREASING THE POWER OF CLINICAL RESEARCH DATA

USPTO serial 87064097

INCREASING THE POWER OF CLINICAL RESEARCH DATA

Reviewed by CopyMark Law Group

Reg. 5164443Status 710
Filing date
Status date
Registration date
Mar 21, 2017
Examiner
SHEN, ELIZABETH S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INCREASING THE POWER OF CLINICAL RESEARCH DATA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anna Kurian Shaw

Anna Kurian Shaw Hogan Lovells US LLP555 13th Street NWWashington, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, customizing ratings reliability activities for business purposes; providing an internet-based database in the field of clinical trials for business purposes featuring business information on complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient-reported outcomes and registries; providing an internet-based database in the field of clinical trials for business purposes featuring business information for monitoring and providing real-time feedback and guidance related to clinical trialsSECTION 8 - CANCELLED—
042Medical and scientific research, data collection and analysis in the nature of clinical research and clinical trials for others in the fields of health care, medical care and pharmaceutical use; providing an internet-based database in the field of clinical trials for pharmaceutical research and development purposes featuring scientific research information on complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient-reported outcomes and registries; providing an internet-based database in the field of clinical trials for pharmaceutical research and development purposes featuring scientific research information for monitoring and providing real-time feedback and guidance related to clinical trialsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2023C8..CANCELLED SEC. 8 (6-YR)—
May 17, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 21, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 16, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 19, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 19, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 9, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 31, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 26, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 19, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 22, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 21, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 3, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 3, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 22, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Nov 21, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 21, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 21, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 15, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Nov 15, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 15, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 15, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 26, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Oct 26, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 26, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 26, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 22, 2016GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 22, 2016GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 22, 2016CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 20, 2016DOCKASSIGNED TO EXAMINER—
Jun 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance